Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical OncologyRevised Neuroblastoma Risk Classification System: A Report from the Children’s Oncology Group

It was time for a change in neuroblastoma treatment planning, and this Original Report from the Journal of Clinical Oncology validates a revised classifier using the International Neuroblastoma Risk Group Staging System (INRGSS) while incorporating segmental chromosome aberrations (SCA) as an additional genomic biomarker.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form